Sign in
4

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001209191-21-037935

Chairman and CEO bought 2,065 shares at an average $1.62 ($3,339)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Niihara Yutaka Chairman and CEO 2021-06-01 Purchase +1,600 $1.61 $2,576 10,755,950 D
Niihara Yutaka Chairman and CEO 2021-06-02 Purchase +465 $1.64 $763 10,756,415 D
Open-market purchases · 2,065 sh · avg $1.62 · $3,339
Loading xslF345X03/doc4.xml…